These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1178955)

  • 21. Assessment of growth hormone reserve: comparison of intravenous arginina and subcutaneous glucagon stimulation tests.
    Podolsky S; Sivaprasad R
    J Clin Endocrinol Metab; 1972 Oct; 35(4):580-4. PubMed ID: 5052976
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucagon stimulation of the anterior pituitary.
    Bloom S; Millar JG; Nabarro JD; Piyasena R; Spathis GS
    J Endocrinol; 1972 Jun; 53(3):43. PubMed ID: 4339042
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of glucagon on the serum levels of free fatty acids and glycerol in children].
    Spahn U; Jablońska-Ulbrych A
    Z Kinderheilkd; 1969; 106(3):213-24. PubMed ID: 5797236
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of ethanol on serum concentrations of somatomedin C and the growth hormone (GH) secretion stimulated by the releasing hormone (GHRH).
    Välimäki M; Pelkonen R; Karonen SL; Ylikahri R
    Alcohol Alcohol Suppl; 1987; 1():557-9. PubMed ID: 3122774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of GH secretion by nonsterefied fatty acids when the stimulox is insulinic hypoglycemia].
    Cabezas-Cerrato J; Villanueva Arangúren L; Casanueva F; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1975 Jul; 138(1):13-8. PubMed ID: 1144881
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of glucagon and of the glucose tolerance test on incretion of the somatotrophic hormone in normal subjects. Comparison of results].
    Giordano G; Marugo M; Minuto F; Barreca T
    Folia Endocrinol; 1971; 24(3):289-97. PubMed ID: 5171731
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of glucagon on the blood serum free fatty acids and glycerol in children].
    Jablońska A; Spahn U
    Pediatr Pol; 1970 Feb; 45(2):155-61. PubMed ID: 5437018
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipolytic effect of intra-arterial injection of glucagon in man.
    Pozza G; Pappalettera A; Melogli O; Viberti G; Ghidoni A
    Horm Metab Res; 1971 Jul; 3(4):291-2. PubMed ID: 5129992
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of adrenaline on insulin-induced release of growth hormone and cortisol in man.
    Müller-Hess R; Geser CA; Jéquier E; Felber JP; Vannotti A
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):260-73. PubMed ID: 4406545
    [No Abstract]   [Full Text] [Related]  

  • 30. [Growth hormone in obesity].
    Oliver C; Jaquet P; Vague P; Martin-Laval C; Argemi B; Djion R
    Rev Fr Endocrinol Clin; 1971; 12(5):425-32. PubMed ID: 4949282
    [No Abstract]   [Full Text] [Related]  

  • 31. Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH.
    Spathis GS; Bloom SR; Jeffcoate WJ; Millar JG; Kurtz A; Pyasena MR; Smith JA; Nabarro JD
    Clin Endocrinol (Oxf); 1974 Apr; 3(2):175-86. PubMed ID: 4366222
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of cyclic AMP on hypothalamo-hypophyseal regulation of secretion of somatotropin].
    Peracchi M; Cavagnini F; Raggi U; Pontiroli AE; Malinverni A
    Folia Endocrinol; 1973 Oct; 26(5):407-11. PubMed ID: 4358215
    [No Abstract]   [Full Text] [Related]  

  • 33. [Somatotropin secretion stimulation test for diencephalic and pituitary diseases, with special reference to the tests using arginine and insulin].
    Nakagawa K; Okamoto M; Horiuchi Y; Mashimo K
    Saishin Igaku; 1969 Nov; 24(11):2333-9. PubMed ID: 5359819
    [No Abstract]   [Full Text] [Related]  

  • 34. [Free fatty acids in the serum--regulatory mechanism and clinical significance].
    Spahn U; Voss E
    Z Arztl Fortbild (Jena); 1969 Mar; 63(5):245-54. PubMed ID: 4894264
    [No Abstract]   [Full Text] [Related]  

  • 35. [Somatotropin hormone levels and growth changes in patients with ataxia-telangectasia].
    Rubio Pérez P; García Urra D; Vila Canella T; Sánchez Sánchez ML; Espinos Pérez D
    Rev Clin Esp; 1978 Nov; 151(3):207-9. PubMed ID: 740993
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of sleep related growth hormone release by elevated free fatty acids.
    Lipman RL; Taylor AL; Schenk A; Mintz DH
    J Clin Endocrinol Metab; 1972 Oct; 35(4):592-4. PubMed ID: 5052978
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostaglandin E1 increases basal glucagon in man.
    Giugliano D; Torella R; Sgambato S; D'Onofrio F
    Pharmacol Res Commun; 1978 Oct; 10(9):813-21. PubMed ID: 724740
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma free fatty acid concentrations in Houssay dogs following a single injection of growth hormone.
    Sirek OV; Sirek A; Przybylska K; Doolan H; Niki A
    Endocrinology; 1967 Aug; 81(2):395-7. PubMed ID: 4952014
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of infused dopamine on free fatty acids in normal females.
    McLellan AR; Shenkin A; Beastall GH; Borland W; Connell JM; Davies DL
    Horm Metab Res; 1989 Mar; 21(3):158-60. PubMed ID: 2744722
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of endogenous growth hormone secretion by exogenous growth hormone infusion in the rhesus monkey.
    Sakuma M; Knobil E
    Endocrinology; 1970 Apr; 86(4):890-4. PubMed ID: 4984004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.